You are here:

AOP Orphan Contact

AOP Orphan worldwide

Wilhelminenstraße 91/IIf
1160 Vienna, Austria

AOP Orphan in portraits

Success through experience and competence

We at AOP Orphan are European pioneers in the field of Orphan Diseases. We research, develop, produce, and distribute innovative solutions for Rare Diseases worldwide.

Dr. Rudolf Widmann established AOP Orphan in Vienna in 1996 in order to provide individualized treatment for patients suffering from Rare Diseases. AOP Orphan has focused particularly on the areas of hematology and oncology, cardiology, neurology, psychiatry and metabolic diseases.

Thanks to years of experience in providing complex individualized treatment, AOP Orphan has acquired significant expertise and developed a strong market presence in the field of Orphan Diseases. The fact that AOP Orphan is privately owned assures a long-term engagement in the market along with high quality services and products. AOP Orphan is also the only provider of key therapies for certain special indications.

AOP Orphan experts work closely with level with leading health care professionals at an international level. This has given them the ability to react quickly to needs and developments and to push research and development projects. When implementing these projects, AOP Orphan has a worldwide network of highly qualified partners that it can reach out to. These strategic alliances make sure that AOP Orphan, as a medium-sized company, is able to compete with top pharmaceutical companies.

Today AOP Orphan is active at an international level with an export ratio of about 70% and has become a leading company in its home market.